Adverse Event reporting information can be found in footer

Request a Meeting

REKOVELLE®

Supporting experience with evidence.

WHAT IS REKOVELLE®?

Delivering personalised medicine through the development of individualised dosing from the start of the first stimulation cycle1
  • Human recombinant follicle-stimulation hormone (FSH)
  • Distinct glycosylation pattern
  • Dosing is based on an innovative algorithm

Rekovelle® resources for healthcare professionals

section product image

Including: how to use Rekovelle®, clinical and real-world evidence, formulations and guidelines

 SEE YOUR RESOURCES

WEBINARS

Here you can access our past webinar and lecture series on demand

 

WATCH WEBINARS
  1. Nyboe Andersen A et al. Fertil Steril 2017; 107(2): 387–396.

Job Code: UK-REK-2300007 - Date of preparation: July 2023

cookiepopup

Our use of cookies

We use cookies (including third party cookies) to collect data while you use this website in order to make it work, keep it secure and comply with regulations. We’d also like your consent to use cookies so we can provide you with tailored content and advertising and analyse how you and other people use the website.

Select “On” to consent to our use of these cookies and continue to the website, or select “Off” to control which types of cookies we use. You can read more about cookies in our Privacy Policy.

Necessary cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics cookies

We’d like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in away that does not directly identify anyone. For more information on how these cookies work, please see our Privacy Policy.